SEDANA — Sedana Medical AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK824.50m
- SEK751.38m
- SEK200.23m
Brief: Sedana Medical Files FDA Approval Application For Isoflurane
Sweden's Sedana Medical Q1 sales fall 7% due to lower ICU patient volumes
Brief: Sedana Medical Q1 Sales SEK 53.4 Million
Sweden's Sedana Medical Q4 sales rise on EU growth
Brief: Sedana Medical Proposes That No Dividend Is Paid For 2025
Brief: Sedana Medical Appoints Mikael Haag As CFO
Brief: CFO Johan Spetz To Leave Sedana Medical
Brief: Sedana Medical Q3 Sales SEK 41.2 Million
Brief: Sedana Medical Q2 Sales SEK 49.8 Million
Brief: Sedana Medical U.S. Studies Meet First Key Secondary Endpoint
Brief: Sedana Medical Q1 EBITDA Loss SEK 0.6 Mln
Brief: Sedana Medical Q1 Sales SEK 57.5 Million
Brief: Sedana Medical Receives FDA Approval For Early Access Program In U.S.
Brief: Sedana Medical Q4 EBIT Loss Narrows To SEK 10.8 Mln
Brief: Sedana Medical Q4 Sales SEK 49.2 Million
Brief: Sedana Medical Gets Additional Year Of Market Protection For Sedaconda
Brief: Sedana Medical's U.S. Trial InspIre-ICU 1 Meets Primary Endpoint
Brief: Sedana Medical Raises Full-Year Guidance
Brief: Sedana Medical Q3 Sales SEK 39.7 Million